Skip to main content
Industry News
No shortage of insulin supplies, top manufacturers say

Lilly, Novo Nordisk and Sanofi assured customers that supplies of insulin and other diabetes medications will be stable throughout the COVID-19 pandemic as fears of drug shortages rise. The three major insulin manufacturers in the US also offer options for patients with diabetes who cannot afford their insulin, but advised patients to prepare for a rise in demand and possible delays in filling prescriptions in the coming days.

Full Story: